T Cells Potentiate PTH-Induced Cortical Bone Loss through CD40L Signaling

Cell Metabolism

Volumn 8, Issue 2, 2008, Pages 132-145

  Gao, Yuhao ^a   Wu, Xiaojun ^a   Terauchi, Masakazu ^a   Li, Jau Yi ^a   Grassi, Francesco ^a   Galley, Sarah ^a   Yang, Xiaoying ^a   Weitzmann, M Neale ^a   Pacifici, Roberto ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

HUMDISEASE

Indexed keywords

CD40 LIGAND; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DISEASE; BONE MARROW; BONE METABOLISM; CATABOLISM; CELL FUNCTION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CORTICAL BONE; DRUG TARGETING; FEMALE; HYPERPARATHYROIDISM; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STROMA CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; BONE AND BONES; BONE MARROW CELLS; CD40 LIGAND; CELL PROLIFERATION; FEMALE; HYPERPARATHYROIDISM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; OSTEOCLASTS; OSTEOPOROSIS; PARATHYROID HORMONE; RANK LIGAND; SIGNAL TRANSDUCTION; STROMAL CELLS; T-LYMPHOCYTES;

MUS;

EID: 48149095459     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2008.07.001     Document Type: Article

References (55)

1. Ahuja S.S., Zhao S., Bellido T., Plotkin L.I., Jimenez F., and Bonewald L.F. CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology 144 (2003) 1761-1769
2. Alexiewicz J.M., Klinger M., Pitts T.O., Gaciong Z., Linker-Israeli M., and Massry S.G. Parathyroid hormone inhibits B cell proliferation: implications in chronic renal failure. J. Am. Soc. Nephrol. 1 (1990) 236-244
3. Calvi L.M., Sims N.A., Hunzelman J.L., Knight M.C., Giovannetti A., Saxton J.M., Kronenberg H.M., Baron R., and Schipani E. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J. Clin. Invest. 107 (2001) 277-286
4. Canalis E., Giustina A., and Bilezikian J.P. Mechanisms of anabolic therapies for osteoporosis. N. Engl. J. Med. 357 (2007) 905-916
5. Cenci S., Toraldo G., Weitzmann M.N., Roggia C., Gao Y., Qian W.P., Sierra O., and Pacifici R. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc. Natl. Acad. Sci. USA 100 (2003) 10405-10410
6. Chen S.H., Pham-Nguyen K.B., Martinet O., Huang Y., Yang W., Thung S.N., Chen L., Mittler R., and Woo S.L. Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation. Mol. Ther. 2 (2000) 39-46
7. Cheng X., Li J., Lu Y., Keyak J., and Lang T. Proximal femoral density and geometry measurements by quantitative computed tomography: association with hip fracture. Bone 40 (2006) 169-174
8. Clark P., and Normansell D.E. Phenotype analysis of lymphocyte subsets in normal human bone marrow. Am. J. Clin. Pathol. 94 (1990) 632-636
9. Clowes J.A., Riggs B.L., and Khosla S. The role of the immune system in the pathophysiology of osteoporosis. Immunol. Rev. 208 (2005) 207-227
10. Corbi A.L., and Lopez-Rodriguez C. CD11c integrin gene promoter activity during myeloid differentiation. Leuk. Lymphoma 25 (1997) 415-425
11. Dempster D.W., Cosman F., Parisien M., Shen V., and Lindsay R. Anabolic actions of parathyroid hormone on bone. Endocr. Rev. 14 (1993) 690-709
12. Dempster D.W., Parisien M., Silverberg S.J., Liang X.G., Schnitzer M., Shen V., Shane E., Kimmel D.B., Recker R., Lindsay R., and Bilezikian J.P. On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 84 (1999) 1562-1566
13. Di Rosa F., and Pabst R. The bone marrow: a nest for migratory memory T cells. Trends Immunol. 26 (2005) 360-366
14. Everts V., Delaisse J.M., Korper W., Jansen D.C., Tigchelaar-Gutter W., Saftig P., and Beertsen W. The bone lining cell: its role in cleaning Howship's lacunae and initiating bone formation. J. Bone Miner. Res. 17 (2002) 77-90
15. Gao Y., Grassi F., Ryan M.R., Terauchi M., Page K., Yang X., Weitzmann M.N., and Pacifici R. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J. Clin. Invest. 117 (2007) 122-132
16. Gao Y., Qian W.P., Dark K., Toraldo G., Lin A.S., Guldberg R.E., Flavell R.A., Weitzmann M.N., and Pacifici R. Estrogen prevents bone loss through transforming growth factor beta signaling in T cells. Proc. Natl. Acad. Sci. USA 101 (2004) 16618-16623
17. Grcevic D., Lee S.K., Marusic A., and Lorenzo J.A. Depletion of CD4 and CD8 T lymphocytes in mice In vivo enhances 1, 25- dihydroxyvitamin D(3)-stimulated osteoclast-like cell formation In vitro by a mechanism that is dependent on prostaglandin synthesis. J. Immunol. 165 (2000) 4231-4238
18. Grey A.B., Stapleton J.P., Evans M.C., and Reid I.R. Accelerated bone loss in post-menopausal women with mild primary hyperparathyroidism. Clin. Endocrinol. (Oxf.) 44 (1996) 697-702
19. Guise T.A., Chirgwin J.M., Favarato G., Boyce B.F., and Mundy G.R. Chinese hamster ovarian cells transfected with human parathyroid hormone-related protein cDNA cause hypercalcemia in nude mice. Lab. Invest. 67 (1992) 477-485
20. Hory B.G., Roussanne M.C., Rostand S., Bourdeau A., Drueke T.B., and Gogusev J. Absence of response to human parathyroid hormone in athymic mice grafted with human parathyroid adenoma, hyperplasia or parathyroid cells maintained in culture. J. Endocrinol. Invest. 23 (2000) 273-279
21. Iida-Klein A., Lu S.S., Kapadia R., Burkhart M., Moreno A., Dempster D.W., and Lindsay R. Short-term continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice. J. Endocrinol. 186 (2005) 549-557
22. Kitaura H., Sands M.S., Aya K., Zhou P., Hirayama T., Uthgenannt B., Wei S., Takeshita S., Novack D.V., Silva M.J., et al. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J. Immunol. 173 (2004) 4838-4846
23. Koh A.J., Demiralp B., Neiva K.G., Hooten J., Nohutcu R.M., Shim H., Datta N.S., Taichman R.S., and McCauley L.K. Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone. Endocrinology 146 (2005) 4584-4596
24. Kong Y.Y., Feige U., Sarosi I., Bolon B., Tafuri A., Morony S., Capparelli C., Li J., Elliott R., McCabe S., et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402 (1999) 304-309
25. Lee S.K., Kadono Y., Okada F., Jacquin C., Koczon-Jaremko B., Gronowicz G., Adams D.J., Aguila H.L., Choi Y., and Lorenzo J.A. T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy. J. Bone Miner. Res. 21 (2006) 1704-1712
26. Li Y., Toraldo G., Li A., Yang X., Zhang H., Qian W.P., and Weitzmann M.N. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 109 (2007) 3839-3848
27. Lotinun S., Evans G.L., Bronk J.T., Bolander M.E., Wronski T.J., Ritman E.L., and Turner R.T. Continuous parathyroid hormone induces cortical porosity in the rat: effects on bone turnover and mechanical properties. J. Bone Miner. Res. 19 (2004) 1165-1171
28. Ma Y.L., Cain R.L., Halladay D.L., Yang X., Zeng Q., Miles R.R., Chandrasekhar S., Martin T.J., and Onyia J.E. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142 (2001) 4047-4054
29. Mehdizadeh S., Alaghband-Zadeh J., Gusterson B., Arlot M., Bradbeer J.N., and Loveridge N. Bone resorption and circulating PTH-like bioactivity in an animal model of hypercalcaemia of malignancy. Biochem. Biophys. Res. Commun. 161 (1989) 1166-1171
30. Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., Reginster J.Y., Hodsman A.B., Eriksen E.F., Ish-Shalom S., Genant H.K., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344 (2001) 1434-1441
31. O'Brien C., Fu Q., Mommsen L., Dusevich V., Bonewald L., Manolagas S.C., and Jilka R.L. Osteoblasts are not the source of RANKL and OPG in bone but are required for maintenance of osteoclast function. J. Bone Miner. Res. 21 (2006) 1111
32. O'Sullivan B., and Thomas R. Recent advances on the role of CD40 and dendritic cells in immunity and tolerance. Curr. Opin. Hematol. 10 (2003) 272-278
33. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., Ott S.M., and Recker R.R. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2 (1987) 595-610
34. Parisien M., Dempster D.W., Shane E., and Bilezikian J.P. Histomorphometric analysis of bone in primary hyperparathyroidism. In: Bilezikian J.P. (Ed). The parathyroids. Basic and clinical concepts (2001), Academic Press, San Diego 423-436
35. Potts J. Primary hyperparathyroidism. In: Krane S. (Ed). Metabolic Bone Diseases. L.V.A.a (1998), Academic Press, San Diego 411-442
36. Qin L., Raggatt L.J., and Partridge N.C. Parathyroid hormone: a double-edged sword for bone metabolism. Trends Endocrinol. Metab. 15 (2004) 60-65
37. Quarles L.D., Yohay D.A., Lever L.W., Caton R., and Wenstrup R.J. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J. Bone Miner. Res. 7 (1992) 683-692
38. Rifas L., and Avioli L.V. A novel T cell cytokine stimulates interleukin-6 in human osteoblastic cells. J. Bone Miner. Res. 14 (1999) 1096-1103
39. Rifas L., and Arackal S. T cells regulate the expression of matrix metalloproteinase in human osteoblasts via a dual mitogen-activated protein kinase mechanism. Arthritis Rheum. 48 (2003) 993-1001
40. Rifas L., Arackal S., and Weitzmann M.N. Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts. J. Cell. Biochem. 88 (2003) 650-659
41. Riggs B.L., and Melton L.J. Medical progress: involutional osteoporosis. N. Engl. J. Med. 314 (1986) 1676-1684
42. Riggs B.L., Khosla S., and Melton III L.J. Sex steroids and the construction and conservation of the adult skeleton. Endocr. Rev. 23 (2002) 279-302
43. Schachter P., Christy M.D., Leight Jr. G.S., and Lobaugh B. Function in athymic nude mice of parathyroid heterografts from patients with primary hyperparathyroidism and secondary hyperparathyroidism. Surgery 108 (1990) 1040-1046
44. Shurtz-Swirski R., Shkolnik T., and Shasha S.M. Parathyroid hormone and the cellular immune system. Nephron 70 (1995) 21-24
45. Silverberg S.J., Shane E., de la Cruz L., Dempster D.W., Feldman F., Seldin D., Jacobs T.P., Siris E.S., Cafferty M., Parisien M.V., et al. Skeletal disease in primary hyperparathyroidism. J. Bone Miner. Res. 4 (1989) 283-291
46. Strieth S., von Johnston V., Eichhorn M.E., Enders G., Krasnici S., Thein E., Hammer C., and Dellian M. A new animal model to assess angiogenesis and endocrine function of parathyroid heterografts in vivo. Transplantation 79 (2005) 392-400
47. Tanaka Y., Maruo A., Fujii K., Nomi M., Nakamura T., Eto S., and Minami Y. Intercellular adhesion molecule 1 discriminates functionally different populations of human osteoblasts: characteristic involvement of cell cycle regulators. J. Bone Miner. Res. 15 (2000) 1912-1923
48. Taubman M.A., and Kawai T. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit. Rev. Oral Biol. Med. 12 (2001) 125-135
49. Teitelbaum S.L. Postmenopausal osteoporosis, T cells, and immune dysfunction. Proc. Natl. Acad. Sci. USA 101 (2004) 16711-16712
50. Toraldo G., Roggia C., Qian W.P., Pacifici R., and Weitzmann M.N. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc. Natl. Acad. Sci. USA 100 (2003) 125-130
51. Uy H.L., Guise T.A., De La Mata J., Taylor S.D., Story B.M., Dallas M.R., Boyce B.F., Mundy G.R., and Roodman G.D. Effects of parathyroid hormone (PTH)-related protein and PTH on osteoclasts and osteoclast precursors in vivo. Endocrinology 136 (1995) 3207-3212
52. Weir E.C., Lowik C.W., Paliwal I., and Insogna K.L. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein. J. Bone Miner. Res. 11 (1996) 1474-1481
53. Weitzmann M.N., and Pacifici R. The role of T lymphocytes in bone metabolism. Immunol. Rev. 208 (2005) 154-168
54. Young N., Mikhalkevich N., Yan Y., Chen D., and Zheng W.P. Differential regulation of osteoblast activity by Th cell subsets mediated by parathyroid hormone and IFN-gamma. J. Immunol. 175 (2005) 8287-8295
55. Zhou H., Shen V., Dempster D.W., and Lindsay R. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. J. Bone Miner. Res. 16 (2001) 1300-1307